557 related articles for article (PubMed ID: 33740349)
1. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
Chen R; Coppes OJM; Urman RD
Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
[TBL] [Abstract][Full Text] [Related]
2. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve.
Labuz D; Spahn V; Celik MÖ; Machelska H
Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963
[TBL] [Abstract][Full Text] [Related]
3. Side Effects of Opioids Are Ameliorated by Regulating TRPV1 Receptors.
Wang X; Bao C; Li Z; Yue L; Hu L
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206575
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
5. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
6. Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.
Knezevic NN; Yekkirala A; Yaksh TL
Anesth Analg; 2017 Nov; 125(5):1714-1732. PubMed ID: 29049116
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.
González-Rodríguez S; Poras H; Menéndez L; Lastra A; Ouimet T; Fournié-Zaluski MC; Roques BP; Baamonde A
Scand J Pain; 2017 Jan; 14():25-38. PubMed ID: 28850427
[TBL] [Abstract][Full Text] [Related]
8. TRPV1-Targeted Drugs in Development for Human Pain Conditions.
Iftinca M; Defaye M; Altier C
Drugs; 2021 Jan; 81(1):7-27. PubMed ID: 33165872
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of hydroalcoholic extract and isoflavone isolated from Polygala molluginifolia in mice: evidence for the involvement of opioid receptors and TRPV1 and TRPA1 channels.
Nucci-Martins C; Nascimento LF; Venzke D; Brethanha LC; Sako AV; Oliveira AS; Brighente IM; Micke GA; Pizzolatti MG; Santos AR
Phytomedicine; 2016 May; 23(5):429-40. PubMed ID: 27064002
[TBL] [Abstract][Full Text] [Related]
10. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
11. Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.
Premkumar LS
AAPS J; 2010 Sep; 12(3):361-70. PubMed ID: 20440589
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effect of (-)-epicatechin in inflammatory and neuropathic pain in rats.
Quiñonez-Bastidas GN; Pineda-Farias JB; Flores-Murrieta FJ; Rodríguez-Silverio J; Reyes-García JG; Godínez-Chaparro B; Granados-Soto V; Rocha-González HI
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):270-279. PubMed ID: 28590304
[TBL] [Abstract][Full Text] [Related]
13. Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies.
Sang CN; Schmidt WK
Neurotherapeutics; 2020 Jul; 17(3):765-769. PubMed ID: 33058022
[No Abstract] [Full Text] [Related]
14. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
16. Central Nervous System Targets: Supraspinal Mechanisms of Analgesia.
Bannister K; Dickenson AH
Neurotherapeutics; 2020 Jul; 17(3):839-845. PubMed ID: 32700132
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.
Liao HY; Hsieh CL; Huang CP; Lin YW
Sci Rep; 2017 Feb; 7():42531. PubMed ID: 28211895
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action.
Nucci-Martins C; Martins DF; Nascimento LF; Venzke D; Oliveira AS; Frederico MJ; Silva FR; Brighente IM; Pizzolatti MG; Santos AR
J Ethnopharmacol; 2015 Dec; 175():273-86. PubMed ID: 26386380
[TBL] [Abstract][Full Text] [Related]
19. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
